Chapter

Implantable cardioverter-defibrillators in heart failure

Rachel C. Myles and Derek T. Connelly

in Oxford Textbook of Heart Failure

Published on behalf of Oxford University Press

ISBN: 9780199577729
Published online July 2011 | e-ISBN: 9780199697809 | DOI: http://dx.doi.org/10.1093/med/9780199577729.003.0047

Series: Oxford Textbooks

Implantable cardioverter-defibrillators in heart failure

Show Summary Details

Preview

The implantable cardioverter-defibrillator (ICD) is established asan effective therapy for ventricular arrhythmias and is now routinelyused for both primary and secondary prevention of suddencardiac death in at-risk populations. Patients with heart failure(HF) have an increased propensity to arrhythmic sudden deathand large randomized trials have demonstrated a clear mortalitybenefit following ICD implantation in selected HF patients. Despitethis, the optimal use of ICDs in patients with HF remains a particularlychallenging area of clinical practice. This is primarily becausepatients with HF are exposed to competing risks, which are both dynamic and difficult to quantify. As the cost and morbidity associatedwith ICD implantation are not insignificant, careful consideration of the risks and benefits associated with ICD implantationin each individual patient is required.

Chapter.  12708 words.  Illustrated.

Subjects: Cardiovascular Medicine

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.